Cancers of the head & neck最新文献

{"title":"Transcriptomics and Epigenomics in head and neck cancer: available repositories and molecular signatures.","authors":"Mara S Serafini,&nbsp;Laura Lopez-Perez,&nbsp;Giuseppe Fico,&nbsp;Lisa Licitra,&nbsp;Loris De Cecco,&nbsp;Carlo Resteghini","doi":"10.1186/s41199-020-0047-y","DOIUrl":"https://doi.org/10.1186/s41199-020-0047-y","url":null,"abstract":"<p><p>For many years, head and neck squamous cell carcinoma (HNSCC) has been considered as a single entity. However, in the last decades HNSCC complexity and heterogeneity have been recognized. In parallel, high-throughput <i>omics</i> techniques had allowed picturing a larger spectrum of the behavior and characteristics of molecules in cancer and a large set of omics web-based tools and informative repository databases have been developed. The objective of the present review is to provide an overview on biological, prognostic and predictive molecular signatures in HNSCC. To contextualize the selected data, our literature survey includes a short summary of the main characteristics of omics data repositories and web-tools for data analyses. The timeframe of our analysis was fixed, encompassing papers published between January 2015 and January 2019. From more than 1000 papers evaluated, 61 omics studies were selected: 33 investigating mRNA signatures, 11 and 13 related to miRNA and other non-coding-RNA signatures and 4 analyzing DNA methylation signatures. More than half of identified signatures (36) had a prognostic value but only in 10 studies selection of a specific anatomical sub-site (8 oral cavity, 1 oropharynx and 1 both oral cavity and oropharynx) was performed. Noteworthy, although the sample size included in many studies was limited, about one-half of the retrieved studies reported an external validation on independent dataset(s), strengthening the relevance of the obtained data. Finally, we highlighted the development and exploitation of three gene-expression signatures, whose clinical impact on prognosis/prediction of treatment response could be high. Based on this overview on omics<i>-related</i> literature in HNSCC, we identified some limits and strengths. The major limits are represented by the low number of signatures associated to DNA methylation and to non-coding RNA (miRNA, lncRNA and piRNAs) and the availability of a single dataset with multiple omics on more than 500 HNSCC (i.e. TCGA). The major strengths rely on the integration of multiple datasets through meta-analysis approaches and on the growing integration among <i>omics</i> data obtained on the same cohort of patients. Moreover, new approaches based on artificial intelligence and informatic analyses are expected to be available in the next future.</p>","PeriodicalId":72518,"journal":{"name":"Cancers of the head & neck","volume":"5 ","pages":"2"},"PeriodicalIF":0.0,"publicationDate":"2020-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s41199-020-0047-y","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37584815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Adaptive radiotherapy for head and neck cancer.","authors":"Howard E Morgan,&nbsp;David J Sher","doi":"10.1186/s41199-019-0046-z","DOIUrl":"https://doi.org/10.1186/s41199-019-0046-z","url":null,"abstract":"<p><strong>Background: </strong>Although there have been dramatic improvements in radiotherapy for head and neck squamous cell carcinoma (HNSCC), including robust intensity modulation and daily image guidance, these advances are not able to account for inherent structural and spatial changes that may occur during treatment. Many sources have reported volume reductions in the primary target, nodal volumes, and parotid glands over treatment, which may result in unintended dosimetric changes affecting the side effect profile and even efficacy of the treatment. Adaptive radiotherapy (ART) is an exciting treatment paradigm that has been developed to directly adjust for these changes.</p><p><strong>Main body: </strong>Adaptive radiotherapy may be divided into two categories: anatomy-adapted (A-ART) and response-adapted ART (R-ART). Anatomy-adapted ART is the process of re-planning patients based on structural and spatial changes occurring over treatment, with the intent of reducing overdosage of sensitive structures such as the parotids, improving dose homogeneity, and preserving coverage of the target. In contrast, response-adapted ART is the process of re-planning patients based on response to treatment, such that the target and/or dose changes as a function of interim imaging during treatment, with the intent of dose escalating persistent disease and/or de-escalating surrounding normal tissue. The impact of R-ART on local control and toxicity outcomes is actively being investigated in several currently accruing trials.</p><p><strong>Conclusions: </strong>Anatomy-adapted ART is a promising modality to improve rates of xerostomia and coverage in individuals who experience significant volumetric changes during radiation, while R-ART is currently being studied to assess its utility in either dose escalation of radioresistant disease, or de-intensification of surrounding normal tissue following treatment response. In this paper, we will review the existing literature and recent advances regarding A-ART and R-ART.</p>","PeriodicalId":72518,"journal":{"name":"Cancers of the head & neck","volume":"5 ","pages":"1"},"PeriodicalIF":0.0,"publicationDate":"2020-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s41199-019-0046-z","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37544851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival.","authors":"Neil Mundi,&nbsp;Stephenie D Prokopec,&nbsp;Farhad Ghasemi,&nbsp;Andrew Warner,&nbsp;Krupal Patel,&nbsp;Danielle MacNeil,&nbsp;Christopher Howlett,&nbsp;William Stecho,&nbsp;Paul Plantinga,&nbsp;Nicole Pinto,&nbsp;Kara M Ruicci,&nbsp;Mohammed Imran Khan,&nbsp;Myung Woul Han,&nbsp;John Yoo,&nbsp;Kevin Fung,&nbsp;Axel Sahovaler,&nbsp;David A Palma,&nbsp;Eric Winquist,&nbsp;Joe S Mymryk,&nbsp;John W Barrett,&nbsp;Paul C Boutros,&nbsp;Anthony C Nichols","doi":"10.1186/s41199-019-0045-0","DOIUrl":"https://doi.org/10.1186/s41199-019-0045-0","url":null,"abstract":"<p><strong>Background: </strong>The genomic landscape of head and neck cancer has been reported through The Cancer Genome Atlas project. We attempt to determine if high-risk human papillomavirus (HPV) or frequently mutated genes are correlated with survival in an oral cancer cohort.</p><p><strong>Methods: </strong>Patient demographic data along with data from final pathology was collected. Tumor DNA was analyzed using a custom Illumina targeted sequencing panel. Five high-risk HPV types were tested by qPCR. Statistical analyses were used to identify associations between patient outcome and mutational status.</p><p><strong>Results: </strong>High-risk HPV types were identified in 7% of cases; HPV status was not associated with survival. Mutations were identified in TP53, TERT promoter, & PIK3CA. Mutations in TP53 were significantly associated with poorer overall survival on multi-variate analysis (<i>p</i> = 0.03).</p><p><strong>Conclusions: </strong>Mutations in TP53 were associated with poor patient survival. Expanding our sample size may identify further predictors of outcome to direct customized cancer care.</p>","PeriodicalId":72518,"journal":{"name":"Cancers of the head & neck","volume":" ","pages":"5"},"PeriodicalIF":0.0,"publicationDate":"2019-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s41199-019-0045-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37463734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The role of salvage surgery with interstitial brachytherapy for the Management of Regionally Recurrent Head and Neck Cancers","authors":"N. Khan, M. Clemens, Jun Liu, A. Garden, A. Lawyer, R. Weber, G. Gunn, W. Morrison, M. Kupferman","doi":"10.1186/s41199-019-0043-2","DOIUrl":"https://doi.org/10.1186/s41199-019-0043-2","url":null,"abstract":"","PeriodicalId":72518,"journal":{"name":"Cancers of the head & neck","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s41199-019-0043-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44743452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"NSD1 mutations by HPV status in head and neck cancer: differences in survival and response to DNA-damaging agents","authors":"Cassie Pan, Said Izreig, W. Yarbrough, N. Issaeva","doi":"10.1186/s41199-019-0042-3","DOIUrl":"https://doi.org/10.1186/s41199-019-0042-3","url":null,"abstract":"","PeriodicalId":72518,"journal":{"name":"Cancers of the head & neck","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s41199-019-0042-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65779718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparing cisplatin-Chemoradiotherapy to Cetuximab-radiotherapy in HPV⁺ \"low-risk\" locally advanced oropharyngeal squamous cell carcinoma: lessons from De-escalate study.","authors":"Panagiota Economopoulou,&nbsp;Amanda Psyrri","doi":"10.1186/s41199-019-0040-5","DOIUrl":"https://doi.org/10.1186/s41199-019-0040-5","url":null,"abstract":"<p><strong>Background: </strong>Human papillomavirus-associated oropharyngeal cancer (HPV-OSCC) is rapidly increasing in incidence and has unique epidemiologic, molecular, and biologic characteristics. Standard combined modality therapies for head and neck cancer confer a significant risk of morbidity. However, patients with HPV-OSCC are diagnosed at a younger age and have a superior prognosis; this spurs the development of treatment deintensification trials that attempt to decrease treatment-related morbidity without compromising efficacy.</p><p><strong>Main body: </strong>The De-Escalate-HPV is a randomized phase 3 study that compares the standard treatment, radiation and cisplatin, with radiation and epidermal growth factor receptor (EGFR) inhibitor cetuximab in patients with low-risk HPV-OSCC.</p><p><strong>Conclusion: </strong>In this commentary, we aim to discuss the results of the De-Escalate-HPV study.</p>","PeriodicalId":72518,"journal":{"name":"Cancers of the head & neck","volume":" ","pages":"1"},"PeriodicalIF":0.0,"publicationDate":"2019-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s41199-019-0040-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37407536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Interventions to improve quality of life (QOL) and/or mood in patients with head and neck cancer (HNC): a review of the evidence.","authors":"Jordan J Senchak,&nbsp;Carolyn Y Fang,&nbsp;Jessica R Bauman","doi":"10.1186/s41199-019-0041-4","DOIUrl":"https://doi.org/10.1186/s41199-019-0041-4","url":null,"abstract":"<p><strong>Background: </strong>Patients with head and neck cancer (HNC) experience significant physical and psychological distress, which have a negative impact on their quality of life (QOL). Few strategies have been studied to help improve QOL in this patient population.</p><p><strong>Results: </strong>In this article, we review the existing literature for intervention studies that focus on improving QOL and/or mood in HNC patients. Our review yielded 14 studies that met criteria. Types of interventions included educational, psychosocial, physical and psychological symptom management, mindfulness, pharmacologic, exercise, and telemedicine. Although the majority of the studies had small sample sizes or other methodological limitations, many showed preliminary feasibility and acceptability with some positive impacts on QOL and/or mood.</p><p><strong>Conclusions: </strong>Larger studies are warranted with more robust randomized designs to determine efficacy of interventions to improve QOL and/or mood in patients with HNC. Additionally, future studies must also consider strategies for implementation and dissemination of these interventions into the health care system to improve the physical and psychological burden of HNC as a population.</p>","PeriodicalId":72518,"journal":{"name":"Cancers of the head & neck","volume":"4 ","pages":"2"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s41199-019-0041-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10050988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"HPV-driven oropharyngeal cancer: current knowledge of molecular biology and mechanisms of carcinogenesis.","authors":"Cassie Pan,&nbsp;Natalia Issaeva,&nbsp;Wendell G Yarbrough","doi":"10.1186/s41199-018-0039-3","DOIUrl":"https://doi.org/10.1186/s41199-018-0039-3","url":null,"abstract":"<p><p>Understanding of oropharyngeal squamous cell carcinoma has significantly progressed over the last decades, and the concept that this disease can be subdivided into two distinct entities based on human papilloma virus (HPV) status has gained acceptance. To combat the constantly growing epidemic of HPV+ oropharyngeal cancer, further investigation and characterization the unique features of the disease, along with the development and implementation of new, targeted therapies, is crucial. In this review, we summarize the etiology, pathogenesis, diagnosis, treatment, and molecular characteristics of HPV-associated oropharyngeal squamous cell carcinoma.</p>","PeriodicalId":72518,"journal":{"name":"Cancers of the head & neck","volume":"3 ","pages":"12"},"PeriodicalIF":0.0,"publicationDate":"2018-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s41199-018-0039-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37407537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Time abides long enough for those who make use of it.","authors":"Muhammad M Fareed,&nbsp;Thomas J Galloway","doi":"10.1186/s41199-018-0038-4","DOIUrl":"https://doi.org/10.1186/s41199-018-0038-4","url":null,"abstract":"<p><p>Increased treatment package time is an independent poor prognostic factor for outcomes in head and neck squamous cell carcinoma (HNSCC). Similarly the timeliness of treatment initiation is a risk factor for disease recurrence. Despite these well-known issues, the timeliness of treatment initiation is actually worsening in the United States and the expeditious completion of radiation treatments continues to be difficult secondary to a number of patients and treatment related issues. This analysis evaluates the current data on treatment intervals in the management of head and neck cancer. Rapid staging/diagnosis of head and neck cancer, appropriate referrals to providers qualified to treat said cancer, and expeditious treatment completion remains the most cost-effective, widely applicable method to improve outcomes in head and neck cancer.</p>","PeriodicalId":72518,"journal":{"name":"Cancers of the head & neck","volume":"3 ","pages":"11"},"PeriodicalIF":0.0,"publicationDate":"2018-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s41199-018-0038-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37247323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Nodal disease predicts recurrence whereas other traditional factors affect survival in a cohort of South African patients with differentiated thyroid carcinoma.","authors":"B Robertson,&nbsp;M Parker,&nbsp;L Shepherd,&nbsp;E Panieri,&nbsp;L Cairncross,&nbsp;F Malherbe,&nbsp;I L Ross,&nbsp;F Omar,&nbsp;A Hunter","doi":"10.1186/s41199-018-0037-5","DOIUrl":"https://doi.org/10.1186/s41199-018-0037-5","url":null,"abstract":"<p><strong>Background and aim: </strong>Information on patients with differentiated thyroid carcinoma in South Africa is limited. The objective of this study was to review demographics and tumour characteristics in a cohort of patients with differentiated thyroid carcinoma, presenting to Groote Schuur Hospital and evaluate risk factors for recurrence and survival.</p><p><strong>Patients and methodology: </strong>Retrospective demographic and clinical data were collected on all patients referred between January 2003 and December 2013. Prognostic factors for recurrence free survival and cancer specific survival were assessed using univariate and multivariate analyses.</p><p><strong>Results: </strong>The total number of patients was 231.The median age at presentation was 44 years and 82% were female patients. The pathological sub-types were papillary (60.6%), follicular (38.9%) and poorly differentiated (0.5%). Total thyroidectomy was performed in 191 patients and 30 patients required neck dissections. A total of 171 (74%) patients received ¹³¹Iodine. The recurrence free and cause specific survival rates at 10 years were 83 and 91%, respectively. Nodal disease at presentation was the only significant risk factor for recurrence (<i>p</i> <  0.001) on multivariate analysis. Significant risk factors for cause specific mortality were age ≥ 45 years (<i>p</i> = 0.006), follicular pathology (<i>p</i> = 0.004), extra-thyroid extension (<i>p</i> = 0.013) and residual tumour (<i>p</i> = 0.004).</p><p><strong>Conclusions: </strong>Consistent with international trends, patients with differentiated thyroid carcinoma treated at Groote Schuur Hospital had a favourable prognosis. The known risk factors associated with recurrence and survival in this South African cohort were consistent with those reported in developed countries.</p>","PeriodicalId":72518,"journal":{"name":"Cancers of the head & neck","volume":"3 ","pages":"10"},"PeriodicalIF":0.0,"publicationDate":"2018-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s41199-018-0037-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37247322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}